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Abstract
We have developed a new method for producing infectious double subgenomic alphaviruses from plasmids
transfected into mammalian cells. A double subgenomic Sindbis virus (TE3’2J) was transcribed from a
cytomegalovirus PolII promoter, which results in the production of infectious virus. Transfection of as little as 125
ng of plasmid is able to produce 1 × 10
8 plaque forming units/ml (PFU/ml) of infectious virus 48 hours post-
transfection. This system represents a more efficient method for producing recombinant Sindbis viruses.
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Background
Alphaviruses (Family: Togaviridae) are used extensively
in molecular biology as tools for gene expression and
delivery [1]. Alphaviruses can infect a wide range of spe-
cies and have small manipulable genomes that can
encode and express heterologous genes [2,3]. Alpha-
viruses possess a positive sense capped RNA that is
approximately 11.6 kb in length. The 5’ end of the viral
RNA is translated into 4 nonstructural proteins (nsP 1-
4) which are involved in replicating the viral genome. A
negative strand RNA is replicated from the full-length
positive strand viral RNA that contains a subgenomic
promoter (SGP) that drives transcription of the 26S sub-
genomic RNA. The subgenomic RNA encodes the viral
structural proteins (Capsid, E3, E2, 6K, and E1) neces-
sary for virion assembly [4]. The SGP has previously
been duplicated in the viral genome, allowing for het-
erologous genes to be expressed from the virus is the
same fashion as the viral structural proteins [5]. Hetero-
logous genes that have been engineered into alphavirus
genomes include fluorescent proteins, luciferases, cellu-
lar proteins, antisense RNAs, and ribozymes [6-12].
Engineering a heterologous gene or RNA behind the
second subgenomic promoter allows for the production
of a fully infectious virus simultaneous with the expres-
sion of the heterologous gene in a wide range of species.
The current method used to create a recombinant
double-subgenomic virus that expresses a heterologous
gene is somewhat inefficient. To insert the gene of inter-
est (GOI) into the virus, the viral infectious clone plas-
mid is digested with a unique restriction enzyme and
the PCR amplified GOI is restriction enzyme digested
and ligated into the virus infectious clone plasmid. This
approach usually results in the GOI ligating in either
the sense or antisense orientation, requiring screening of
the resulting clones for the orientation of the insert. Of
additional concern with single-site restriction cloning is
multiple copies of the GOI ligating into the virus infec-
tious clone plasmid if small inserts are used. Once a
clone with the GOI in the correct orientation has been
identified and sequenced, the plasmid is linearized using
a unique restriction site at the end of the viral genome
to allow for run-off RNA transcription. Several micro-
grams of phenol-chloroform extracted plasmid DNA is
used in in vitro RNA transcription reactions with a
nucleotide cap analog to generate capped viral RNAs.
The RNA is then either electroporated into cells or
transfected with chemical or liposomal RNA transfection
reagents, and virus is collected from culture media 24-
72 hours later.
Several points in this process reduce efficiency and
increase time of virus production. Insertion of a GOI
into the viral genome by restriction cloning is relatively
inefficient due to the need to screen for insert orienta-
tion. In vitro RNA transcription kits that are commonly
used are expensive and generally result in low yields of
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tion). Additionally, phage DNA-dependent RNA poly-
merases (such as T7 and SP6) have low fidelity and can
result in quasi-species from the in vitro transcription
reaction [13]. Electroporation of cells with RNA requires
large numbers of cells (1-5 × 10
6 cells/electroporation),
is sensitive to salt concentration that can damage cells
during electroporation, and require specialized equip-
ment not always available in laboratories. Chemical and
liposomal RNA transfection has been used more
recently to avoid using electroporation, but RNA degra-
dation during transfection is still a concern.
To make alphavirus expression systems easier to use
and more accessible to researchers, we have developed
virus expression plasmids that are simple to manipulate
and can rapidly and inexpensively produce infectious
virus. Building on our previous work with Sindbis virus
replicon expression plasmids [14], we generated a dou-
ble-subgenomic Sindbis virus expression plasmid that
transcribes RNA from a cytomegalovirus (CMV) PolII
promoter and cleaves the RNA at the 3’ end of the viral
genome similar to plasmid-based replicon expression
systems [14-16]. In addition, we have developed variants
of this system that utilize recombination technology to
rapidly and efficiently insert a GOI into the virus in the
desired orientation. The negative and positive selection
capability of the Gateway cloning system makes it
attractive for rapid GOI cloning. Using this system we
have produced several reporter gene expressing viruses
and demonstrate their use in cell culture.
Methods
Plasmid Construction
The base TE/3’2J Sindbis virus expression plasmid
(pBG167) was constructed by digesting a TE/3’2J replicon
expression plasmid pBG68 [14] with HpaI and XbaI
restriction enzymes and ligating the vector with T4 DNA
ligase to a 4631 bp XbaI/HpaI fragment from the pTE/3’2J
infectious clone [17]. pBG218 was created by ligating NheI
flanked GFP open reading frame into the unique XbaI site
in pBG167. The orientation of the GFP insert was verified
by sequencing with BG626 (5’ CACCTCTAGACCATG-
GATCC) and BG583 (5’ CTAGATAAATGGTTAATA-
TAGT). pBG167-based recombination ready plasmids
were generated by ligating a PCR amplified attR1/attR2
recombination cassette from Gateway pDEST32 (Invitro-
gen) into pBG167. BG121 (5’ CATGGCTAGCACAA
GTTTGTACAAAAAAGCTGAACG) and BG122 (5’
CATGGCTAGCACCACTTTGTACAAGAAAGCTGA
ACG) contain NheI restriction sites, and were used to
ligate the recombination cassette into XbaI digested
pBG167 and were transformed into ccdB resistant DB 3.1
E. coli cells (Invitrogen). Forward and reverse attR1/attR2
recombination cassettes were identified by DNA
sequencing and resulted in pBG210 and pBG211, respec-
tively. pBG440 (pENTR-D/Topo-GFP) and pBG403
(pENTR-D/Topo-Renilla Luciferase) were constructed by
PCR amplifying the eGFP gene from pIE-GFP (Clontech)
with primers BG518 (5’ CACCGCTAGCATGGGGATG-
CATGGTACCATGG) and BG519 (5’ AAGTGCTAGCT-
TACTTGTACAGCTCGTCCATGCC) or the Renilla
luciferase gene from pWN5’RucPur [18] with primers
BG556 (5’ CACCATGGCTAGCAAGGTGTACGACC)
and BG557 (5’ CTACTGCTCGTTCTTCAGCACG) and
incubating the gel extracted PCR products with pENTR-
D/Topo. pBG344 (pENTR-D/TOPO-mCherry) was pro-
duced by incubating the mCherry gene PCR amplified
from pmCherry (Clontech) with primers BG504 (5’ CAC-
CAGATCTATGGTGAGCAAGGGCGAGGAGG) and
BG505 (5’ CATGAGATCTTTACCGGTGCTTGTA-
CAGCTCGTCC) with pENTR-D/Topo. BG212 was gen-
erated by performing a LR Clonase II reaction between
pBG440 and pBG210, pBG451 was generated from a LR
Clonase II Reaction between pBG403 and pBG210, and
pBG452 was generated from a LR Clonase II reaction
between pBG344 and pBG210.
All viral sequences in pBG167 plasmid were verified
with a panel of Sindbis-specific primers. Inserts ligated
into the unique XbaI site in pBG167 were sequenced
with primers BG 583 (5’ CTAGATAAATGGTTAATA-
TAGT) and BG626 (5’ CACCTCTAGACCATGGATCC)
to verify sequence and orientation. PCR products that
were Topo-cloned into pENTR-D/Topo were sequenced
with M13-20 and M13 Reverse primers. All Gateway
attR1/attR2 containing plasmids were grown on ccdB
resistant DB3.1 E. coli cells (Invitrogen), and all other
plasmids were grown in DH5a E. coli cells. Diagrams of
each virus expression construct are provided in Figure 1.
Cell Culture and Transfection
Baby Hamster Kidney (BHK) and Vero cells were main-
tained in Hyclone DMEM supplemented with 10% fetal
bovine serum (FBS), 5% Pen/Strep, and 5% L-Glutamine
[18]. These mammalian cells were kept in a 37°C incu-
bator with 5% CO2. BHK cells were plated in 6-well
plates for transfection with Lipofectamine 2000 (Invitro-
gen). Cells were transfected at 60% confluency with 125
ng DNA per well following the manufacturer’sr e c o m -
mendations. Transfection media was removed and
replaced with fresh media 6-8 hours post transfection.
Aedes albopictus C6/36 cells were cultured in L-15 med-
ium with 10% FBS, 5% Pen/Strep, and 5% L-Glutamine
and were maintained at 28°C [19].
Plaque Assays and Growth Curves
Viral titers were determined using plaque assay titra-
tions on BHK cells as described previously [20]. BHK
cells seeded on 24 well tissue culture plates were
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at 37°C, and then an agarose nutrient overlay was
added. Cells were maintained at 37°C for 3 days for visi-
ble plaques to develop. On day 3, Thiazolyl Blue Tetra-
zolium Blue (MTT) at 5 mg/ml in PBS was added to
the overlay to visualize plaques and incubated at 37°C
for 12 hrs. Viral plaques were counted and titers deter-
mined as plaque forming units (PFU)/ml.
P0 (transfection initiated) and P1 (virus initiated)
growth curves were performed in 6-well plates. For P0
growth curves, BHK cells were transfected as described
above. The cells were washed with media to remove
excess transfection complexes, and 500 μl samples were
collected at 4, 8, 12, 24, 36, 48, 60, and 72 hours post
transfection. Sample volumes collected were replaced
with fresh media to maintain a total volume of 2 ml.
Aliquots of samples were stored at -80°C until titration
or infection. For P1 growth curves, titered P0 derived
virus (48 hr post-transfection) was added to BHK or
Vero cells at MOI = 0.1 or 0.01 as indicated. Samples
were collected and analyzed as described for P0 growth
curves. Each growth curve was replicated three times,
and average titers and standard error calculated. Data
was graphed using Microsoft Excel.
GFP, mCherry, and Renilla Luciferase expression
GFP and mCherry expressing cells were imaged on an
inverted Nikon Photopt fluorescence microscope with a
CoolSnap CCD camera using either 488 nM/535 nM fil-
ters for GFP detection, 560 nM/630 nM filters for
mCherry detection, or phase contrast for cell imaging.
Image contrast was adjusted for all images equally using
ImageJ software. Luciferase assays were performed using
Viviren Live Cell Renilla Luciferase Reagent (Promega)
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Figure 1 Plasmid constructs. The full-length double subgenomic Sindbis genome TE3’2J was engineered behind a cytomegalovirus promoter
(CMV), and a 3’ hepatitis delta virus ribozyme (HDV) was added after a 35 base adenine repeat (A35) to cleave the viral RNA from the over
length transcript. pBG167 possess a unique XbaI site after the second SGP, and is analogous to pTE3’2J [17]. pBG218 is pBG167 with GFP inserted
at XbaI site via ligation between the unique XbaI site in pBG167 and engineered NheI sites flanking the GFP ORF. pBG210 and pBG211 have the
attR1/attR2 Gateway Recombination Cassettes ligated into the pBG167 XbaI site in forward and reverse orientation, respectively. pBG212 is the
product of a LR Clonase reaction between pBG210 and pBG440 and places GFP in the sense orientation. pBG213 is a recombination between
pBG211 and pBG440, and places GFP in the reverse orientation. pBG451 is the product of a recombination between pBG210 and pBG403, and
places Renilla luciferase in the sense orientation. pBG452 is the product of a recombination between pBG210 and pBG344 and places mCherry in
the sense orientation.
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times media was removed from the infected wells and
replaced with 25 μL DMEM supplemented with 37 μg/
ul Viviren reagent. The plates were incubated at 37°C
for 10 minutes, then relative light units (RLU) in each
well were determined on a Victor 3 V Multimode pla-
tereader (Perkin Elmer). All experiments were per-
formed at least 3 independent times, and averages and
standard errors are reported.
Results and Discussion
Production of infectious Sindbis viruses from plasmid
transfections
To test if infectious Sindbis virus could be produced
from plasmid pBG167 (Figure 1), 125 ng of pBG167
plasmid was transfected with Lipofectamine 2000 into a
single well of BHK cells in a 6-well plate. 4 hrs post
transfection the cells were washed with media to remove
excess transfection complexes, and media samples were
collected at the indicated times post transfection (Figure
2A). Viral growth kinetics and maximal viral titers are
similar to TE3’2J produced from RNA transcripts [9,21],
indicating that a simple transfection of Sindbis virus
expression plasmid produces similar amounts of virus as
traditional production methods.
Once we determined that infectious Sindbis virus could
be produced directly from transfected pBG167 plasmid,
we generated a series of constructs with GFP inserted
behind the 3’ SGP either by ligation into the XbaI site
(pBG218) or by recombination into a Gateway attR1/
attR2 recombination cassette in plasmids pBG210 or
pBG211 (pBG212, and pBG213). These plasmids were
stably propagated in E. coli in the pcDNA3.1 vector back-
bone with average plasmid miniprep yields of 100 ng/μl
(data not shown), and were able to produce infectious
virus in passage 0 (P0) growth curves (Figure 2A). We
observed that the maximal titers for each GOI containing
clone was lower than pBG167-derived virus, which has
been reported previously from transcription-derived
TE3’2J viruses [9]. To determine if the plasmid derived
v i r u s e sw e r ea b l et or e p l i c a t ei nas e c o n dp a s s a g e( P 1 ) ,
we infected BHK cells with each P0 virus at MOI = 0.01
and determined growth kinetics (Figure 2B). The P1 viral
growth kinetics and maximal titers were much more uni-
form that the P0, which may be accounted for by differ-
ing molar amounts of plasmid being transfected in the P0
samples due to differing plasmids sizes. Therefore the
system was able to produce infectious virus.
Reporter Gene Expression
We next tested reporter gene expression from each
virus. pBG212 and pBG218 derived virus both produced
GFP expression as visualized by fluorescence micro-
scopy, whereas pBG213 derived virus with GFP inserted
in reverse orientation and pBG167 did not express GFP
(Figure 3A). We also tested the kinetics of GOI expres-
sion using P0 Renilla luciferase expressing virus derived
from pBG451 on BHK cells. The kinetics of Renilla luci-
ferase expression in the P1 infection closely followed the
kinetics of virus production in growth curve assays (Fig-
ure 3B), indicating that viral replication and reporter
gene expression were closely linked. The slight delay in
PFU production as compared to Renilla luciferase activ-
ity at 8 hrs post infection likely reflects that the subge-
nomic promoters are functioning and producing Renilla
luciferase and viral structural proteins, but the virions
had not had time to assemble into infectious viruses at
that point. To verify that reporter gene expression is
sensitive to a known viral replication inhibitor, we trea-
ted cells with the cellular calmodulin kinase inhibitor
W-7 (N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfona-
mide hydrochloride) that had previously been shown to
A B
Figure 2 Production of Infectious Sindbis Viruses. A) P0 viral titers from plasmid transfected BHK cells. 125 ng of plasmid DNA transfected
with Lipofectamine 2000 reagents. Media samples were collected at the indicated times and viral titers were determined by plaque assays as
plaque forming units (PFU)/ml. B) P1 viral titers in BHK cells. BHK cells were infected at MOI = 0.01 with 48 hr P0 viruses, then samples were
collected at the indicated times and viral titers were determined by plaque assay.
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Page 4 of 8interfere with viral packaging [22]. 20 μM W-7 treat-
ment reduced reporter gene expression by about 1 log
in P1 infections as compared to untreated samples (Fig-
ure 3C), demonstrating that Renilla luciferase expression
was linked to viral replication.
Replication of plasmid derived virus in various cell lines
Sindbis is known for broad tropism and is able to infect
different species with relatively similar efficiencies. We
determined if plasmid-derived virus was able to replicate
well in cell lines other than BHK cells. Renilla luciferase
expressing pBG451 virus (P0) was used to infect BHK
(murine), Vero (primate), and C6/36 (mosquito) cell
lines at MOI = 0.1, and viral titers and Renilla luciferase
activity were assessed at 48 hrs post infection (P1)
(Figure 4). BHK cells and Vero cells produced similar
titers 48 hrs post infection (~1 × 10
6 PFU/ml), and
showed similar Renilla luciferase signals at 48 hrs (~1 ×
10
5 RLU). C6/36 cells produced lower titers and Renilla
luciferase signal than BHK and Vero cells at 48 hrs post
infection, though this difference may be due to slower
growth kinetics in invertebrate cell lines. These data
indicate that the P0 virus was able to effectively infect
and replicate in both murine, primate, and mosquito
cell lines, and that the Renilla luciferase reporter gene
was expressed in each cell line during the P1 infection.
Stability of Reporter Gene Expression
To test the stability of the att-containing viruses, we
passaged the mCherry containing pBG452 virus 3
Phase GFP
167
213
212
218
A B
C
Figure 3 Expression of Heterologous Genes from Recombinant Sindbis Viruses. A) Fluorescence microscopy of BHK cells infected with GFP
or non-GFP expressing viruses. BHK cells were infected with P0 virus at MOI = 0.01. At 48 hrs post infection, phase contrast and GFP
fluorescence was detected at 10× magnification. B) Expression of Renilla Luciferase from pBG451. BHK cells were infected with P0 derived
pBG451 virus at MOI = 0.1, and media samples were collected for plaque assay at the indicated times. In parallel, Renilla luciferase activity was
detected in pBG451 infected cells using Viviren Live Cell Renilla Luciferase Reagent as described in the Materials and Methods section. C)
Reduction of Renilla luciferase activity in the presence of a viral replication inhibitor. HEK 293T cells were infected in triplicate with P0 derived
pBG451 virus at MOI = 0.1. At 4 hrs post infection cells were either mock treated or treated with 20 uM W-7. Renilla luciferase assays were
performed at the indicated times as described in the Materials and Methods section. All reported values are the average of three independent
experiments.
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for each infection. We collected media after 48 hrs for
each passage, and after the 3
rd passage we infected
naïve BHK or C6/36 cells with virus from passage at
MOI = 0.01. We observed that each cell type showed
equal fluorescence with each passage at 28 hrs post-
infection (BHK) and 86 hrs post-infection (C6/36) (Fig-
ure 5), indicating that the att-flanked GOI remained
stable over the course of at least 3 passages in both
BHK and C6/36 cells.
Figure 4 Replication and Heterologous Gene Expression in Cell Lines from Different Species. BHK (murine), Vero (primate) and C636
(mosquito) cell lines were infected with P0 derived pBG451 virus at MOI = 0.1. Renilla luciferase assays and plaque titrations were performed in
triplicate on each cell line at 48 hours post infection.
Wϭ
WϮ
Wϯ
,< ϲϯϲ
Figure 5 Stability of Reporter Gene Expression. BHK or C636 cell lines were infected with P0 derived pBG452 virus at MOI = 0.01 for 48 hrs,
then media was collected and titered. This process was repeated for a total of 3 passages. After the 3
rd passage, BHK or C6/36-derived virus
from each passage was added to BHK or C6/36 cells at MOI = 0.01 and incubated for 28 (BHK) or 86 (C6/36) hrs. mCherry fluorescence was
detected at the indicated times by fluorescence microscopy.
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Page 6 of 8The typical sequence of events for production of a
GOI expressing TE’32J virus takes approximately 3-4
weeks. Cloning and inserting the GOI 3’ of the viral
subgenomic promoter usually takes ~2 weeks from the
PCR amplification step and requires screening clones
for insert orientation. Once a clone has been identified
and the GOI sequenced, the production of infectious
RNA takes 2-3 additional days due to preparation of lin-
earized maxiprepped plasmid DNA for in vitro tran-
scription and electroporation of RNA transcripts into
~2-10 × 10
6 cells using expensive electroporation sys-
tems. Additionally, becauseR N Ai sb e i n gu s e d ,e x t r a
precautions to reduce RNase degradation of transcripts
must be used. Therefore, the traditional production of
GOI expressing TE3’2 Jc a nb et i m ec o n s u m i n ga n d
somewhat expensive.
Our system circumvents many of the problems asso-
ciated with production of GOI expressing TE3’2J
viruses. GOI PCR products can be rapidly cloned into
attL containing pENTR-D/Topo vectors, then the GOI
can be recombined into pBG210 (forward) or pBG211
(reverse) TE3’2J expression plasmids with high effi-
ciency. In our hands this process take about 1 week
and is highly efficient. The pENTR-D/Topo vector and
LR Clonase II systems from Invitrogen are relatively
expensive, but each reaction can be scaled down to
reduce costs and extend the number of reactions that
can be performed. We have successfully recombined
short hammerhead ribozymes (67 bp) and the large
F i r e f l yl u c i f e r a s eg e n e( 1 . 6K b )i n t op B G 2 1 0( d a t an o t
shown), indicating that a wide range of insert sizes can
be accommodated. Once the GOI containing virus
expression plasmid has been constructed, virus is pro-
duced by transfecting a small amount of the plasmid
into BHK cells using common transfection agents and
2×1 0
5 cells in a single well. Virus is produced within
a few days with minimal effort. The format for trans-
fection can be adjusted from 96-well plates to T150
flasks as needed, making virus production very flexible
and rapid. GOI expression was verified from several
viruses, including viruses that produce GFP and Renilla
luciferase (Figures 3 and 4). The kinetics of Renilla
luciferase expression closely mirrored viral replication
kinetics, indicating that the GOI is stable and can be
used as a readout for viral replication as previously
described [7-9].
Conclusions
In this report we describe the construction and charac-
terization of a new Sindbis (TE3’2J) virus production
system. The virus expression plasmids we describe have
several features that make them useful for rapidly gen-
erating Sindbis viruses that express genes of interest.
We have developed a system by which fully infectious
reporter gene expressing virus can be produced simply
by transfecting a small amount of virus expression plas-
mid into cultured mammalian cells. Genes of interest
can be rapidly incorporated into viruses in specific
orientations via Gateway recombination. High-titer virus
produced from our system can infect multiple cell types
in culture and maintain reporter gene expression. The
ease of cloning and specificity of insert orientation
would make this system ideal for generating libraries of
infectious viruses expressing randomized trans-cleaving
ribozymes or inverted cDNA libraries to screen for host
genes that are involved in viral replication or antiviral
responses. In addition, the ability to launch virus pro-
duction directly in cells with stable plasmid DNA may
open up the possibility of using these constructs for
stable Sindbis virus vaccines that can be launched via
plasmid injection that may provide more robust
immune responses than non-spreading replicon
vaccines.
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